CausalSentinel

Protein Dossier — CCL21 (C-C motif chemokine 21)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Total cholesterol 0.0646 0.013 6.98e-07 Wald ratio 1 trans NA
LDL cholesterol 0.0646 0.0133 1.30e-06 Wald ratio 1 trans NA
Age at menopause -0.181 0.0494 2.46e-04 Wald ratio 1 trans NA
Height 0.028 0.00774 2.98e-04 Wald ratio 1 trans NA
Non-cancer illness code self-reported: high cholesterol 0.0548 0.016 6.46e-04 Wald ratio 1 trans NA
HOMA-IR 0.028 0.00988 0.00461 Wald ratio 1 trans NA
Lung adenocarcinoma -0.222 0.0789 0.00493 Wald ratio 1 trans NA
Iron -0.0697 0.0254 0.00602 Wald ratio 1 trans NA
Triglycerides 0.0319 0.012 0.00787 Wald ratio 1 trans NA
HOMA-B 0.0214 0.00807 0.00798 Wald ratio 1 trans NA
Serum creatinine (eGFRcrea) 0.0056 0.00214 0.00891 Wald ratio 1 trans NA
Paget’s disease -0.375 0.145 0.00995 Wald ratio 1 trans NA
…and 109 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-2516_57_3 6Ckine Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

34 association rows across 23 traits (31 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
CCL27 protein levels 1e-67 rs10814133 1 GCST90468579 no MR -> candidate analysis
CCL21 protein levels 2e-55 rs10814138 1 GCST90468573 no MR -> candidate analysis
Circulating CCL21 levels 2e-54 rs10814138 1 GCST90860611 no MR -> candidate analysis
Circulating CCL19 levels (id: OID00513_OID21030) 1e-50 rs10972202 1 GCST90859869 no MR -> candidate analysis
Circulating CCL19 levels (id: OID00794_OID21030) 1e-29 rs10972202 1 GCST90860126 no MR -> candidate analysis
CCL19 protein levels 2e-29 rs11574915 1 GCST90468571 no MR -> candidate analysis
COVID-19 hospitalization or rheumatoid arthritis (MTAG) 3e-19 rs10972201 1 GCST90255368 no MR -> candidate analysis
C-C motif chemokine 19 levels 8e-18 rs11574915 1 GCST90274765 no MR -> candidate analysis
Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic c 6e-16 rs2812378 2 GCST90132225 no MR -> candidate analysis
Rheumatoid arthritis 2e-15 rs11574914 10 GCST002318 no MR -> candidate analysis
Height 3e-13 rs10124246 1 GCST90245844 MR: beta=0.028, p=2.98e-04 (trans)
Lymphocyte count 1e-12 rs11574914 1 GCST90002320 no MR -> candidate analysis
…and 11 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 926 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
rheumatoid arthritis 0.809 common-variant locus no MR -> candidate analysis
autoimmune disease 0.54 common-variant locus no MR -> candidate analysis
ulcerative colitis 0.541 common-variant locus MR: beta=-0.0239, p=0.47 (trans)
Crohn disease 0.541 common-variant locus no MR -> candidate analysis
psoriasis 0.541 common-variant locus no MR -> candidate analysis
ankylosing spondylitis 0.541 common-variant locus no MR -> candidate analysis
sclerosing cholangitis 0.541 common-variant locus no MR -> candidate analysis
COVID-19 0.304 common-variant locus no MR -> candidate analysis

Of the 8 rows above, 7 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=0.00066, LOEUF=1.18 — LoF-tolerant
GWAS Catalog 59 unique SNPs / 118 rows
ClinVar 103 records; 8 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance